Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Glenmark Pharmaceuticals ltd Share Issue/Capital Change 2018

Nov 13, 2018

62608_rns_2018-11-13_33d2ac40-402b-4089-b468-1f1a3254cb4b.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [131 x 63] intentionally omitted <==

pursuanttoEmployee Stock Options Scheme, 2016:
NumberofOptions Granted 20,000 OptionsEachOption represents 1 EquitysharesofRe.1each
NumberofOrdinarysharescovered under the Optionsgranted 20,000 equity sharesofRe.1each
Vesting periodr Tocommence after a periodofone year from thedateofthe grant and extend upto a maximum periodofsixyears from the dateofthegrant
Exercise Period Tocommence from the dateofvestingofstockoptionsandmayextend till the expiry ofthe scheme
Exercise Price Rs.600per Option